NZ512256A - Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus - Google Patents

Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus

Info

Publication number
NZ512256A
NZ512256A NZ51225601A NZ51225601A NZ512256A NZ 512256 A NZ512256 A NZ 512256A NZ 51225601 A NZ51225601 A NZ 51225601A NZ 51225601 A NZ51225601 A NZ 51225601A NZ 512256 A NZ512256 A NZ 512256A
Authority
NZ
New Zealand
Prior art keywords
cells
injected
polyacrylamide gel
cultivated
diabetes mellitus
Prior art date
Application number
NZ51225601A
Inventor
Dmitry Vladimirovich Zybin
Alexei Gennadievich Kotelevits
Sergei Evgenievich Severin
Vladimir Konstantinovi Sologub
Ljubov Leonidovna Mironova
Original Assignee
Alexei Gennadievich Kotelevits
Sergei Evgenievich Severin
Vladimir Konstantinovich Solog
Dmitry Vladimirovich Zybin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexei Gennadievich Kotelevits, Sergei Evgenievich Severin, Vladimir Konstantinovich Solog, Dmitry Vladimirovich Zybin filed Critical Alexei Gennadievich Kotelevits
Publication of NZ512256A publication Critical patent/NZ512256A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A polyacrylamide gel is useful in the preparation of a medicament for introducing into the tissue of a mammal to form a connective tissue capsule. Transplanted heterologous cells are then inserted into the capsule formed in the mammal and the cells are cultivated. The transplanted cells produce biologically active components, induce immunity or supplement levels of a substance that is either deficient or absent in the mammal. It is useful for the treatment of diabetes mellitus whereby the cells may be pancreatic b-cells and in treatment of cancer Also described is a method of cultivating heterologous cells within a non-human mammal, which comprises introducing into the tissue a polyacrylamide gel that forms a connective tissue capsule and subsequently introducing the heterologous cells into the capsule.
NZ51225601A 2000-06-23 2001-06-08 Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus NZ512256A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000116208A RU2165263C1 (en) 2000-06-23 2000-06-23 Method of treatment of patients with diabetes mellitus

Publications (1)

Publication Number Publication Date
NZ512256A true NZ512256A (en) 2002-10-25

Family

ID=20236573

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ51225601A NZ512256A (en) 2000-06-23 2001-06-08 Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus

Country Status (3)

Country Link
AU (1) AU784765C (en)
NZ (1) NZ512256A (en)
RU (1) RU2165263C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498142B1 (en) 2002-04-10 2007-03-21 Obschestvo S Organichennoy Otvetstvennostyu "Vitagel" Polyfunctional biocompatible hydrogel and method for the production thereof
TW202006136A (en) * 2010-05-07 2020-02-01 北卡羅來納大學教堂山 Method of engrafting cells from solid tissues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972194B1 (en) * 1999-12-08 2005-12-06 Dmitry Vladimirovich Zybin Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic and xenogenic cells

Also Published As

Publication number Publication date
RU2165263C1 (en) 2001-04-20
AU5179501A (en) 2002-01-10
AU784765B2 (en) 2006-06-15
AU784765C (en) 2007-01-11

Similar Documents

Publication Publication Date Title
IS4083A (en) Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals
GB0001309D0 (en) Valve arrangement
WO2002004001A3 (en) A composition for the delivery of live cells and methods of use
DE60126637D1 (en) MICROSTRUCTURES FOR THE TREATMENT AND PREPARATION OF THE SKIN
WO2003002243A3 (en) Method and device for electrochemical formation of therapeutic species in vivo
ATE340581T1 (en) METHOD FOR TREATING PROSTATE DISEASES USING DELAYED AND/OR EXTENDED RELEASE VITAMIN D FORMULATIONS
ID22689A (en) METHODS FOR ACTIVATING CELLS THAT PROVIDE HUMAN ANTIGENT PROPERTIES, ACTIVATED CELLS THAT INDICATE HUMAN ANTIGENT PROPERTIES, AND ITS USE
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
AU7432796A (en) Retrievable bioartificial implants
GB0500787D0 (en) Integration of meningococcal conjugate vaccination
EP1555955A4 (en) Method for administering thermotherapy to prevent the growth of tumors
BR9612051A (en) Medical implant
DE69633278D1 (en) DEVICE FOR DELIVERING A SELECTED MOLECULE INTO THE CIRCUIT SYSTEM
ATE212230T1 (en) METHODS OF DISEASE TREATMENT USING SERTOLI CELLS AND ALLOTRANSPLANT OR XENOTRANSPLANT
WO2007030512A3 (en) Graft implant containing drug crystals
AU2002343045A1 (en) A needleless injector drug capsule and a method for filling thereof
WO2001023421A3 (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU2001265151A1 (en) Method of stimulating hair growth
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
NZ512256A (en) Polyacrylamide gel injected in vivo into the tissue forming capsules wherein desired cells (such as beta-islet pancreatic cells) are injected into and cultivated for treating oncological diseases and diabetes mellitus
ATE382378T1 (en) IMPLANT MATERIAL
WO2003059262A3 (en) Method and composition for treating and preventing hiv infection and aids
EP1151756A4 (en) Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
DK1377320T3 (en) Polynucleotide binding complexes comprising sterols and saponins
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN

Legal Events

Date Code Title Description
PSEA Patent sealed
ASS Change of ownership

Owner name: VERCELL BIOTECHNOLOGY BV, NL

Free format text: OLD OWNER(S): ALEXEI GENNADIEVICH KOTELEVITS; SERGEI EVGENIEVICH SEVERIN; VLADIMIR KONSTANTINOVICH SOLOGUB; DMITRY VLADIMIROVICH ZYBIN

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)